Abstract. The pathological scaling in recessive x-linked ichthyosis is associated with accumulation of
Introduction
Recessive x-linked ichthyosis (RXLI)' is an uncommon disorder of cornification which is characterized clinically by excessive scaling due to prolonged stratum corneum retention. Previously characterized by inheritance pattern and clinical presentation (1) , this disorder can now be diagnosed biochemically because of the recent discovery that patients with RXLI lack the enzyme steroid sulfatase (2, 3) . Presumably, as a consequence of steroid sulfatase deficiency in skin and other tissues (4) (5) (6) , one substrate, cholesterol sulfate, accumulates in red blood cells (7) , serum (7, 8) , and stratum corneum (9) . In contrast, sulfated steroid hormones, such as dehydroepiandrosterone sulfate, that are also substrates of this enzyme in vitro, do not accumulate in either blood or urine (8, 10 ).
Yet, despite this array of new biochemical data, the pathogenesis of the scaling abnormality in RXLI is still not understood. Because of the unique localization of lipids to the intercellular regions of the stratum corneum (1 1), we have suspected that lipids may regulate stratum corneum cohesion and desquamation (12) . Thus, the scaling abnormality in RXLI might be attributable to accumulation of cholesterol sulfate within stratum corneum cell membrane domains (13, 14) . Here, we report (a) that both the enzyme and its substrate are concentrated within the outer epidermis in normal human and rodent epidermis, and that within these layers, they are localized to membrane regions (15) ; and (b) that cholesterol sulfate itself, when repeatedly applied to normal stratum corneum, produces scale (16) . These findings may provide a subcellular basis not only for disease expression, but also for the process of normal desquamation (14) .
Methods
Preparations of human and neonatal mouse epidermal cell layers. Normal human skin (n = 8) was obtained from fresh autopsy (abdomen) or fresh surgical (abdominoplasty/mammoplasty) full-thickness specimens. By floating specimens dermis-side downward on culture fluid that contained 10 mg/ml of a crude preparation of staphylococcal epidermolytic toxin for 2 h at 370C, we obtained homogeneous, undamaged sheets of stratum corneum and stratum granulosum (17) . Further incubations of sheets over 0.5% trypsin in phosphate-buffered saline (PBS), pH 7.4, for 2 h at 370C provided homogeneous populations of stratum corneum and stratum granulosum. Trypsinization was halted by the addition of excess soybean trypsin inhibitor (Sigma Chemical Co., St. Louis, MO), and the granular cells were dislodged by vortexing followed by filtering three times through several layers of cheesecloth. Basal and spinous cells were liberated by gently scraping the freshly denuded surface of toxin-split full-thickness skin specimens with a 15 surgical blade. The homogeneity of each epidermal cell layer-stratum corneum, stratum granulosum, and stratum basale/ spinosum-was assessed by phase and electron microscopy (I 1). Nucleated cells were absent in stratum corneum preparations after trypsinization, and conversely, a complete absence of cornified cells was noted in granular cell pellets. Since basal/spinous layer preparations contained neither collagen nor flattened squames, these preparations apparently represented cells that were derived solely from the lower epidermis.
Five patients with RXLI, documented by prior enzymatic assay (5) , consented to having 1-cm2 shave biopsies performed from clinically involved sites on the trunk comparable to controls, i.e., back or abdomen, followed by in vitro splitting as described above for normals. Parallel studies were performed in neonatal mouse epidermis, which possesses a comparable spectrum of epidermal lipids to human epidermis (11, 12) . The subsequent steps for preparation of stratum granulosum and stratum basale/spinosum followed those described above for human epidermis.
Development of an animal model. To test the hypothesis that cholesterol sulfate within the stratum corneum provokes excessive scale, we applied cholesterol sulfate (Research Plus, Bayonne, NJ), dehydroepiandrosterone sulfate (DHEAS, Sigma Chemical Co.) dissolved in dimethyl sulfoxide (DMSO) , and cholesterol (Sigma Chemical Co.) dissolved in DMSO/chloroform (50:50, vol) to the backs of hairless mice (Hr/Hr, Jackson Labs, Bar Harbor, ME). Some animals received trace amounts of 3H-cholesterol sulfate in addition to cold cholesterol sulfate that was synthesized from 3H-cholesterol (New England Nuclear, Boston, MA) and purified as described elsewhere (16) . A total of 1.0-2.0 mg of each chemical or vehicle alone was applied daily to a circumscribed 1-cm2 area. Animals were housed individually and wore a specially constructed collar to insure that they did not lick themselves or other animals. Biopsies were obtained at 0, 1, 3, and 7 wk, and processed for light microscopy followed by hematoxylin and eosin staining, or for lipid extraction and fractionation (see below).
Preparation of subcellular fractions. Recently, a new protocol has been developed for the purification of membrane preparations from both human and neonatal mouse stratum corneum, which traps most of the stratum corneum lipids in the intercellular spaces (18) . Briefly summarized, the freshly prepared stratum corneum sheets were snapfrozen in aluminum foil under liquid nitrogen and pulverized into a fine powder on a submerged aluminum block with a precooled hammer. The (18) . The membranes were then pelleted at 30,000 g and the supernatants saved.
Assessment ofsteroid sulfatase (SS) activity. The whole cell, broken cell, and supernatant fractions were homogenized in iced 0.014 M Tris-HC1 buffer, pH 8.0, using a Polytron PT-10 (Brinkmann Instruments Inc., Westbury, NY) with one or two 10-s bursts at maximal speed, and the enzyme assays were performed on the Miranol-extracted fractions by measurement of desulfation of 3H-DHEAS as previously described (8) . All incubations were performed in duplicate. Enzyme activity was expressed as picomoles of 3H-DHEAS converted to benzene-soluble 3H-DHEAS per hour incubation per milligram protein.
Protein quantity was measured by the Lowry method, by hydrolysis in 6 N HC1, and analysis in an amino acid analyzer (19) . The results were comparable by either method.
Cholesterol sulfate assay. The cholesterol sulfate content of portions of the stratum basale/spinosum, stratum granulosum, and the stratum corneum fractions from eight normals and five RXLI patients was assessed by sequential, quantitative thin-layer chromatography (TLC) as described recently (9, 11) . Because of its limited lipid solubility, cholesterol sulfate is found not only in the organic phase, but also in the aqueous-methanol phase unless 0.1 M KCI is added to the extraction mixture, which drives all of the cholesterol sulfate into the lipidcontaining infranatants (9) . After fractionation of lipid extracts in tetrahydrofuran/methylal/methanol:4 M ammonium hydroxide (60:30:10:4, vol), the cholesterol sulfate-containing fraction from the normal skin samples, visualized by black light fluorescence after spraying with the fluorophore, 8-anilino-I-naphthalene sulfonic acid, was excised, extracted in Bligh-Dyer solvents (19, 20) that contained 0.1 M KCl, and measured colorimetrically by the Franey-Amador method (21). This method accurately detects quantities of cholesterol sulfate in the 25-1,000 Ag range. The assignment of the cholesterol sulfate fraction was confirmed by co-chromatography against the authentic compound in three solvent systems, and by mass spectrometry after solvolysis ( Fig. 1) (19) .
Results
Steroid sulfatase activity. Because the various cell layers and subcellular fractions were exposed to different incubation conditions, e.g., epidermolytic toxin and proteolytic enzymes (trypsin, subtilisin), the impact of these conditions on SS activity was assessed in human placental microsomes, human leukocyte extracts, and stratum granulosum homogenates. After 30-min, 1-h, and 2-h incubations with trypsin, subtilisin, or epidermolytic toxin, we noted no diminution of enzyme activity (data not shown).
Stratification of SS in epidermis (tables I-III). In both human and neonatal mouse epidermis, little SS activity was present in the stratum basale/spinosum fraction (Tables I and  III) . However, in both the human and mouse, a sudden and dramatic increase in activity appeared in the stratum granu- losum and stratum corneum (Tables I and III) . In both human and neonatal mouse, SS activity in the stratum granulosum and stratum corneum was approximately equal (Tables I and   III ). In contrast, no enzyme activity was found in any epidermal layer from the RXLI patient (Table I) . Subcellular localization ofSS in stratum corneum. In both normal human and mouse stratum corneum, the bulk of enzyme activity (4-to 12-fold excess) appeared in the peripheral membrane preparations (Table II , mouse data not shown). In comparison, supernatants generally contained <10% of the activity found in the purified membranes (Table II) . In contrast, neither RXLI whole stratum corneum nor RXLI stratum corneum membranes displayed enzyme activity (Tables I  and II) .
Cholesterol sulfate levels and localization in normal and RXLI epidermis. Whereas the cholesterol sulfate content of normal human stratum corneum rarely exceeds 5% of the total lipid (9), an apparent gradient occurred during maturation from the inner to the outer epidermis (Table IV) . The levels present in the stratum granulosum were significantly higher than those found in the lower epidermis and consistently higher than stratum corneum levels, although the difference did not achieve statistical significance (Table IV) . In RXLI viable epidermal cell layers, cholesterol sulfate levels were only slightly higher than normal viable epidermal cell layers (Table  IV) . But in contrast to normals, the levels in RXLI continued to rise into the stratum corneum (Fig. 2, Table IV (16) .
Clinical scaling was accompanied by histologic evidence of a direct effect on the stratum corneum (Fig. 4) (23) . t Results of stratum granulosum vs. spinosum/basale in normal epidermis and of stratum corneum vs. stratum granulosum or stratum spinosum/basale in RXLI, are statistically significant (P < 0.01, < 0.05, respectively). However, differences between normal stratum corneum and stratum granulosum do not achieve significance (P < 0.1).
sulfate content doubles levels encountered in control stratum corneum. Shorter application times produce intermediate cholesterol sulfate levels without evidence scale (Table V) . Cholesterol content was lower in treated scaling sites than untreated or treated nonscaling sites, but these differences were not significant.
Discussion
Previous studies have demonstrated that absence of the enzyme, steroid sulfatase, in RXLI is associated with accumulation of cholesterol sulfate in erythrocytes (7), serum (8) , and stratum corneum (9) . The possibility that the increased cholesterol sulfate in RXLI stratum corneum results from passive accumulation of circulating cholesterol sulfate seems unlikely, since the concentration of cholesterol sulfate in serum and erythrocyte membranes in RXLI are an order of magnitude less than the levels encountered in normal epidermis, and two orders of (26) . Secondly, the increased cholesterol sulfate content of RXLI scale is accompanied by a reduction in free sterols (9) , and a recent report describes correction of scale in RXLI after topical application of cholesterol (27) . We have recently demonstrated that cholesterol sulfate inhibits sterologenesis in cultured fibroblasts and keratinocytes by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting step in cholesterol synthesis (28). The issue of the relative importance of increased cholesterol sulfate or decreased cholesterol in RXLI stratum corneum to the pathogenesis of disease remains to be resolved. However, the demonstration in hairless mice of scaling after topical application of cholesterol sulfate, where little seems to penetrate to the viable epidermis, supports a direct, provocative role for cholesterol sulfate per se.
Still unanswered is the question of localization of disease to the skin in RXLI. One explanation for localization of disease to skin, and for the paucity of extracutaneous organ involvement in RXLI, may be the epidermis' unusually great capacity to generate large quantities of sulfated sterols (24, 25) . We have recently hypothesized that a cholesterol sulfate cycle is operative in the epidermis, and that interruption of this sulfation-desulfation cycle leads to the scaling in RXLI (14) . Alternatively, there may be other mechanisms for desulfation of sterols in extracutaneous tissue. 
£
Another important aspect of this study is the possibility that steroid sulfatase is an effector of physiologically normal desquamation. Such a link between enzyme and substrate, in relation to normal desquamation, is fortified not only by the parallel concentration of enzyme and substrate in the outer epidermis, but also by their localization specifically to peripheral cell membrane domains in the stratum corneum. This abrupt shift in enzyme localization from intracellular membranes to the cell periphery during the transition from the stratum granulosum to the stratum corneum presumably reflects insertion into the plasma membrane of intracellular membrane fragments, including lamellar bodies, which are the secretory organelle that delivers epidermal lipids to the intercellular spaces (12) . This relocation process synchronously places the enzyme in close proximity to those membrane regions where cholesterol sulfate is segregated. To further substantiate this hypothesis it will be necessary to find evidence of progressive desulfation of cholesterol sulfate within the stratum corneum itself. In addition, positive proof for a relationship between desulfation and desquamation requires demonstration of sulfatase activity in stratum corneum in vivo, rather than in detergent extracts, as shown here. If such activity could be demonstrated, then the stratum corneum might yet be shown to possess a broad spectrum of metabolic activities that could govern its own functions, and not to be "dead" as generally accepted.
The molecular mechanism(s) whereby cholesterol sulfate might influence cohesion is still unknown. Two possibilities that are under active consideration include: first, that abnormal lipid thermal transitions would result from an altered intercellular lipid mix (29); or second, that intermolecular crosslinking between cholesterol sulfate moieties on adjacent cell membranes, which are mediated by divalent cations, would increase cohesion (13) .
